Also trades as: CVSG.L (LSE) · $vol 4M

$16.60

+0.00 (+0.00%)

OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 51 · $1.1B mcap · 68M float · 0.0005% daily turnover · Short 100% of daily vol

Revenue

$701M -24.1% ▼

5Y CAGR: +6.6%

Gross Profit

$285M -20.1% ▼

5Y CAGR: +5.1%

Operating Income

$76M -22.8% ▼

5Y CAGR: +13.7%

Net Income

$17M -67.8% ▼

5Y CAGR: -2.5%

EPS (Diluted)

$0.24 -35.1% ▼

5Y CAGR: -2.3%

EBITDA

$140M -11.0% ▼

5Y CAGR: +9.7%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$554M	$589M	$647M	$924M	$701M
YoY Growth	+8.6%	+6.3%	+9.9%	+42.8%	-24.1%
Cost of Revenue	$315M	$331M	$369M	$568M	$416M
Gross Profit	$239M	$258M	$278M	$357M	$285M
Gross Margin	43.1%	43.8%	42.9%	38.6%	40.6%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$196M	$190M	$227M	$236M	$209M
Operating Expenses	$196M	$190M	$227M	$258M	$209M
Operating Income	$43M	$68M	$51M	$99M	$76M
Operating Margin	7.7%	11.6%	7.8%	10.7%	10.8%
Interest Expense	$7M	$8M	$13M	$24M	$15M
Income Before Tax	$36M	$61M	$38M	$45M	$31M
Tax Expense	$10M	$12M	$12M	$19M	$14M
Net Income	$26M	$42M	$6M	$53M	$17M
Net Margin	4.6%	7.1%	1.0%	5.7%	2.4%
EPS (Diluted)	$0.36	$0.59	$0.09	$0.37	$0.24
EBITDA	$90M	$103M	$108M	$157M	$140M
Shares Outstanding	72M	72M	72M	72M	71M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$296M	$312M	$160M	$327M	$342M	$582M	$357M	$358M
Cost of Revenue	$181M	$188M	$189M	$181M	$193M	$375M	$212M	$212M
Gross Profit	$115M	$124M	$141M	$137M	$149M	$208M	$145M	$145M
Gross Margin	38.9%	39.8%	88.0%	41.9%	43.5%	35.7%	40.6%	40.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$82M	$89M	$112M	$115M	$122M	$114M	$110M	$103M
Operating Expenses	$82M	$89M	$112M	$115M	$122M	$136M	$110M	$103M
Operating Income	$33M	$36M	$16M	$19M	$26M	$72M	$35M	$42M
Operating Margin	11.2%	11.4%	9.9%	5.9%	7.7%	12.4%	9.8%	11.9%
Interest Expense	$4M	$5M	$10M	$2M	$9M	$15M	$7M	$9M
Income Before Tax	$28M	$26M	$27M	$11M	$17M	$27M	$15M	$17M
Tax Expense	$7M	$5M	$9M	$3M	$6M	$12M	$7M	$7M
Net Income	$21M	$21M	$15M	-$8M	$11M	$15M	$8M	$10M
Net Margin	7.1%	6.7%	9.1%	-2.6%	3.3%	2.6%	2.2%	2.7%
EPS (Diluted)	$0.29	$0.29	$0.20	$-0.11	$0.16	$0.15	$0.11	$0.14
EBITDA	$40M	$47M	$35M	$64M	$50M	$107M	$68M	$75M
Shares Outstanding	72M	72M	72M	72M	72M	72M	72M	69M

CVSGF OTC